A multicultural group practicing yoga together in a bright studio

Embody vs Yucca Health: GLP-1 Comparison 2026

Embody vs Yucca Health: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified October 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated November 7, 20264 min read

Quick answer

Yucca Health typically wins on sticker price for compounded GLP-1. Both prescribe compounded medication, so compare them on the specific product, plan term, and terms you'd actually be buying rather than on program positioning.

Side-by-side comparison

Feature	Embody	Yucca Health
Best for	Personalized compounded blends and hands-on support	Low advertised entry price on compounded GLP-1 with plain FDA disclosures and all-50-state provider coverage
Medication type	Compounded GLP-1 with personalization	Compounded semaglutide and tirzepatide, once-weekly injection ('Semaglutide+' / 'Tirzepatide+'); also sells NAD+ and Sermorelin (out of registry scope)
Pricing model	Monthly subscription, formulation-tiered	6-month prescription plans billed monthly/quarterly/6-month; advertised new-patient entry pricing; full pricing shared after intake
Semaglutide price	Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-10-21; confirm current price at checkout	Compounded, $69/mo on the 12-month plan ($828 billed per term); $75/mo on the 6-month plan; $89/mo month-to-month. Verified 2026-11-07.
Tirzepatide price	Compounded tirzepatide / GLP-1+GIP, $119/mo (flat pricing shown on the verified offer page), verified 2026-10-21; no 'was' comparison price shown for tirzepatide specifically, confirm at signup.	Compounded, $119/mo on the 12-month plan ($1,428 billed per term); $125/mo on the 6-month plan; $139/mo month-to-month. Verified 2026-11-07.
Key watchout	Embody's published price is a live time-limited promo with no confirmed standing rate: it changed intra-day on 2026-07-14 ($99/mo AM, '$200 OFF, was $299', to $149/mo PM, '$150 OFF, was $299'), and by 2026-08-21 the same offer URL had dropped further to a new low. We rank it at its current verified purchasable price ($69/mo semaglutide) and label it a promo, confirm the exact cost at checkout. Custom blends also warrant scrutiny on ingredient transparency. The offer page also states 'In Nebraska, services are limited to patients 19 years of age or older.'	The $125/mo figure is the 6-month-commitment semaglutide rate ($750 billed every 6 months) and carries Yucca's own 'Exclusive Lifetime Offer, Coupon Auto-Applied' banner; 3-month is $140/mo and month-to-month is $146/mo. Yucca states 'Your price stays flat at every dose level' but publishes no per-dose price list. Per the refund page (read 2026-10-06) the order is final once a clinician issues the prescription. Pharmacies are not named.
Price checked	Checked October 21, 2026	Checked November 7, 2026 · an automated check re-read it November 10, 2026

When to choose Embody

You want a compounded program that personalizes the formulation
You're comfortable evaluating ingredient lists and provider transparency
You'd value bundled adjuncts (anti-nausea, B12, etc.) when offered
You're escalating dose and want a provider that adjusts with you

Check current Embody pricing →

When to choose Yucca Health

You want a low advertised entry price on compounded semaglutide or tirzepatide
You value an upfront 'not FDA-approved' compounding disclosure in the FAQ
You want provider coverage in all 50 states with free 2-day shipping
You're comfortable confirming your exact ongoing rate at intake (pricing beyond the entry offer is shared after eligibility)

Check current Yucca Health pricing →

Full reviews

Frequently asked questions

Is Embody cheaper than Yucca Health?

Neither Embody nor Yucca Health is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, Embody or Yucca Health?

Both Embody and Yucca Health prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Embody and Yucca Health compounded or brand-name?

Embody offers compounded glp-1 with personalization. Yucca Health offers compounded semaglutide and tirzepatide, once-weekly injection ('semaglutide+' / 'tirzepatide+'); also sells nad+ and sermorelin (out of registry scope). If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Embody to Yucca Health?

Yes, switching between Embody and Yucca Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Embody and Yucca Health to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-10-21; confirm current price at checkout and Compounded, $69/mo on the 12-month plan ($828 billed per term); $75/mo on the 6-month plan; $89/mo month-to-month. Verified 2026-11-07. are starting tiers, not your guaranteed long-term cost.